Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products:

Tumor Marker Test

MPX Test

DPX Test

Automated Immunoassay Analyzer

Immunochemistry Analyzer

More products

Download Mobile App

Video Library

Events

more events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

03 Apr 2023 - 06 Apr 2023

MSACL 2023 – Congress of the Association for Mass Spectrometry & Advances in Clinical Lab

14 Apr 2023 - 16 Apr 2023

AACR 2023 – Annual Meeting of the American Association for Cancer Research

15 Apr 2023 - 18 Apr 2023

ECCMID 2023 – 33rd European Congress of Clinical Microbiology and Infectious Diseases

Roche Introduces Digital Health Solutions Under Navify Brand

By LabMedica International staff writers
Posted on 08 Nov 2022

Image: The navify portfolio uses digital solutions, analytics and data science to provide health insights (Photo courtesy of Roche)

Roche (Basel, Switzerland) has announced that its digital health portfolio will now be available under the navify brand. The navify digital solutions help providers and patients 'navigate' and 'clarify' a wide range of touchpoints by activating insights that provide evidence on how to optimize operational processes and clinical decision making in healthcare.

Together, navify brings new ways to improve interoperability of digital infrastructure, use advanced analytics to deliver operational excellence, improved workflows, and patient-centric ways of working, and generate advanced medical insights that augment clinical decision support. The portfolio across Roche includes more than 30 digital solutions for labs, hospitals and patients worldwide and many key initiatives to advance digital transformation in healthcare. Several late stage pilots with customers and tech collaborators are underway for digital infrastructure (navify Core Integrator), operational excellence (navify Sample Tracking) and for medical insights (navify Screening for Cervical Cancer, navify Kidney Companion and navify Algorithm Suite).

With navify Marketplace, Roche connects labs and healthcare providers and third-party medtech and other companies to help bring innovations to healthcare. Several startups or companies are involved and more are joining: Smart4Diagnostics, imito (wound.app), decide Clinical Software (glucotab), Glytec, Precordior (CardioSignal), SteadySense (SteadyTemp), Deigma, TestCard, Etheclo, Tracie Healthcare Solutions and Binary Tech. Medial EarlySign, which develops AI-based clinical predictive analytics, is the latest to join, allowing for EarlySign ColonFlag to be accessible to labs and hospitals via the navify platform in the near future.

"Today we are using navify digital solutions, such as algorithms, and data science to deliver insights that are actionable in healthcare, building on three decades of software experience with diagnostics in laboratories," said Moritz Hartmann, Head of Roche Information Solutions. "We are creating open digital ecosystems with labs, hospitals and medtech companies to bring the latest innovations faster to society to better serve patients, and to support clinicians in providing care for patients. These activities support our strategy to deliver insights that drive personalised care."

Related Links:
Roche